Global Biochip Scanner Market-Industry Analysis and Forecast (2019-2027) – By Type, End User, and Region.

Global biochip scanner market size was US$ XX Bn in 2019 and is expected to reach US$ XX Bn by 2027, at a CAGR of ~18% during the forecast period.   Global Biochip Scanner Market To know about the Research Methodology :- Request Free Sample Report The report study has analyzed the revenue impact of COVID -19 pandemic on the sales revenue of market leaders, market followers, and market disrupters in the report, and the same is reflected in our analysis.

Global biochip scanner market Definition

Biochips are miniature version of the laboratories and are the most significant part of molecular biology. Biochips are generally used to perform thousands or hundreds of biochemical reactions at the same time. A biochip scanner is a device that is used to discover and obtain fluorescence signal data from biochips or biological microchips and these devices consist of a laser to emit a laser beam and scan the particular rows of the biochips.

Global biochip scanner market Dynamics

A biochip scanner market has witnessed an ample growth from the past few years. The growth of the biochip scanner market is primarily driven by its growing significance in various biomedical applications. An increasing requirement to reduce turnaround time, rising demand of biochip scanners for researches and diagnostics activities to perform clinical tests, growing technological advancements and rising applications of biochips, ongoing research and development activities in large-scale genomic and proteomic field and advances in nanotechnology are expected to improve growth of the market during the forecast period. However, high cost of biochip scanners, risks of hazardous problems of individual privacy and high complexity of biological systems are major restraining factors that could hamper the growth of the market.

Global Biochip Scanner Market: Segmentation Analysis

By type, the DNA chip segment dominated the market in 2019 and is projected to witness fast growth at a CAGR of XX% during the forecast period. Increasing investments in research activities and rising demand for next-generation and advanced genetic disorder diagnosis and detection tools are attributed to the growth of the market. A rising adoption of DNA chips in applications such as gene expression profiling, to identify novel drugs, to discover the dissimilarities in gene expression levels in cells and to detect the mutations in specific genes is expected to improve growth of the market during the forecast period.

Global Biochip Scanner Market: Regional Analysis

Region-wise, North America held the largest market share in 2019 and is expected to maintain its dominance at a CAGR of XX% during the forecast period. The US and Canada are the major key contributors behind the growth of the market. The growth is attributed to the growing technological advancements in the biomedical field across the region. Growing adoption of biochip scanners in research laboratories and increasing use of biochip scanning technology in drug development, clinical research, toxicology studies, diagnostics and in various clinical trials is driving the growth of the market in the NA region. The objective of the report is to present a comprehensive analysis of the Global Biochip Scanner Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding Global Biochip Scanner Market dynamics, structure by analyzing the market segments and projects the Global Biochip Scanner Market. Clear representation of competitive analysis of key players by Application, price, financial position, Product portfolio, growth strategies, and regional presence in the Global Biochip Scanner Market make the report investor’s guide.

The Scope of Global Biochip Scanner Market: Inquire before buying

Global Biochip Scanner Market, By Type

• DNA Chips • Lab-On-A-Chip • Protein Chips • Cancer Diagnosis and Treatment • Gene Expression • Single Nucleotide Polymorphism (SNP) Genotyping • Genomics • Drug Discovery • Others (Agricultural Biotechnology, Proteomics, Expression Profiling, High Throughput Screening)

Global Biochip Scanner Market, By End User

• Biotechnology & Pharmaceutical Companies • Hospitals & Diagnostics Centers • Academic & Research Institutes

Global Biochip Scanner Market, By Region

• North America  US  Canada • Europe  UK  France  Germany  Italy  Spain  Norway  Russia • Asia Pacific  China  India  Japan  South Korea  Australia  Malaysia  Indonesia • South America  Brazil  Mexico  Argentina • Middle East and Africa

Global Biochip Scanner Market, Key Players

• Agilent Technologies, Inc • Bio-Rad Laboratories, Inc • Cepheid Inc • Fluidigm Corporation • GE Healthcare • Hoffman-La-Roche Ltd • Illumina, Inc • Ocimum Biosolutions Ltd • PerkinElmer, Inc • Takara Bio Inc • Thermo Fisher Scientific Inc • Merck Millipore • Sigma-Aldrich Corporation • Abbott Laboratories • XX • XX
Global Biochip Scanner Market 1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Biochip Scanner Market Size, by Market Value (US$ Bn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global Biochip Scanner Market Analysis and Forecast 6.1. Biochip Scanner Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Biochip Scanner Market Analysis and Forecast, By Type 7.1. Introduction and Definition 7.2. Key Findings 7.3. Biochip Scanner Market Value Share Analysis, By Type 7.4. Biochip Scanner Market Size (US$ Bn) Forecast, By Type 7.5. Biochip Scanner Market Analysis, By Type 7.6. Biochip Scanner Market Attractiveness Analysis, By Type 8. Global Biochip Scanner Market Analysis and Forecast, By End User 8.1. Introduction and Definition 8.2. Key Findings 8.3. Biochip Scanner Market Value Share Analysis, By End User 8.4. Biochip Scanner Market Size (US$ Bn) Forecast, By End User 8.5. Biochip Scanner Market Analysis, By End User 8.6. Biochip Scanner Market Attractiveness Analysis, By End User 9. Global Biochip Scanner Market Analysis, by Region 9.1. Biochip Scanner Market Value Share Analysis, by Region 9.2. Biochip Scanner Market Size (US$ Bn) Forecast, by Region 9.3. Biochip Scanner Market Attractiveness Analysis, by Region 10. North America Biochip Scanner Market Analysis 10.1. Key Findings 10.2. North America Biochip Scanner Market Overview 10.3. North America Biochip Scanner Market Value Share Analysis, By Type 10.4. North America Biochip Scanner Market Forecast, By Type 10.4.1. DNA Chips 10.4.2. Lab-On-A-Chip 10.4.3. Protein Chips 10.4.4. Cancer Diagnosis and Treatment 10.4.5. Gene Expression 10.4.6. Single Nucleotide Polymorphism (SNP) Genotyping 10.4.7. Genomics 10.4.8. Drug Discovery 10.4.9. Others (Agricultural Biotechnology, Proteomics, Expression Profiling, High Throughput Screening) 10.5. North America Biochip Scanner Market Value Share Analysis, By End User 10.6. North America Biochip Scanner Market Forecast, By End User 10.6.1. Biotechnology & Pharmaceutical Companies 10.6.2. Hospitals & Diagnostics Centers 10.6.3. Academic & Research Institutes 10.7. North America Biochip Scanner Market Value Share Analysis, by Country 10.8. North America Biochip Scanner Market Forecast, by Country 10.8.1. U.S. 10.8.2. Canada 10.9. North America Biochip Scanner Market Analysis, by Country 10.10. U.S. Biochip Scanner Market Forecast, By Type 10.10.1. DNA Chips 10.10.2. Lab-On-A-Chip 10.10.3. Protein Chips 10.10.4. Cancer Diagnosis and Treatment 10.10.5. Gene Expression 10.10.6. Single Nucleotide Polymorphism (SNP) Genotyping 10.10.7. Genomics 10.10.8. Drug Discovery 10.10.9. Others (Agricultural Biotechnology, Proteomics, Expression Profiling, High Throughput Screening) 10.11. U.S. Biochip Scanner Market Forecast, By End User 10.11.1. Biotechnology & Pharmaceutical Companies 10.11.2. Hospitals & Diagnostics Centers 10.11.3. Academic & Research Institutes 10.12. Canada Biochip Scanner Market Forecast, By Type 10.12.1. DNA Chips 10.12.2. Lab-On-A-Chip 10.12.3. Protein Chips 10.12.4. Cancer Diagnosis and Treatment 10.12.5. Gene Expression 10.12.6. Single Nucleotide Polymorphism (SNP) Genotyping 10.12.7. Genomics 10.12.8. Drug Discovery 10.12.9. Others (Agricultural Biotechnology, Proteomics, Expression Profiling, High Throughput Screening) 10.13. Canada Biochip Scanner Market Forecast, By End User 10.13.1. Biotechnology & Pharmaceutical Companies 10.13.2. Hospitals & Diagnostics Centers 10.13.3. Academic & Research Institutes 10.14. North America Biochip Scanner Market Attractiveness Analysis 10.14.1. By Type 10.14.2. By End User 10.15. PEST Analysis 10.16. Key Trends 10.17. Key Developments 11. Europe Biochip Scanner Market Analysis 11.1. Key Findings 11.2. Europe Biochip Scanner Market Overview 11.3. Europe Biochip Scanner Market Value Share Analysis, By Type 11.4. Europe Biochip Scanner Market Forecast, By Type 11.4.1. DNA Chips 11.4.2. Lab-On-A-Chip 11.4.3. Protein Chips 11.4.4. Cancer Diagnosis and Treatment 11.4.5. Gene Expression 11.4.6. Single Nucleotide Polymorphism (SNP) Genotyping 11.4.7. Genomics 11.4.8. Drug Discovery 11.4.9. Others (Agricultural Biotechnology, Proteomics, Expression Profiling, High Throughput Screening) 11.5. Europe Biochip Scanner Market Value Share Analysis, By End User 11.6. Europe Biochip Scanner Market Forecast, By End User 11.6.1. Biotechnology & Pharmaceutical Companies 11.6.2. Hospitals & Diagnostics Centers 11.6.3. Academic & Research Institutes 11.7. Europe Biochip Scanner Market Value Share Analysis, by Country 11.8. Europe Biochip Scanner Market Forecast, by Country 11.8.1. Germany 11.8.2. U.K. 11.8.3. France 11.8.4. Italy 11.8.5. Spain 11.8.6. Norway 11.8.7. Russia 11.8.8. Rest of Europe 11.9. Europe Biochip Scanner Market Analysis, by Country 11.10. Germany Biochip Scanner Market Forecast, By Type 11.10.1. DNA Chips 11.10.2. Lab-On-A-Chip 11.10.3. Protein Chips 11.10.4. Cancer Diagnosis and Treatment 11.10.5. Gene Expression 11.10.6. Single Nucleotide Polymorphism (SNP) Genotyping 11.10.7. Genomics 11.10.8. Drug Discovery 11.10.9. Others (Agricultural Biotechnology, Proteomics, Expression Profiling, High Throughput Screening) 11.11. Germany Biochip Scanner Market Forecast, By End User 11.11.1. Biotechnology & Pharmaceutical Companies 11.11.2. Hospitals & Diagnostics Centers 11.11.3. Academic & Research Institutes 11.12. U.K. Biochip Scanner Market Forecast, By Type 11.12.1. DNA Chips 11.12.2. Lab-On-A-Chip 11.12.3. Protein Chips 11.12.4. Cancer Diagnosis and Treatment 11.12.5. Gene Expression 11.12.6. Single Nucleotide Polymorphism (SNP) Genotyping 11.12.7. Genomics 11.12.8. Drug Discovery 11.12.9. Others (Agricultural Biotechnology, Proteomics, Expression Profiling, High Throughput Screening) 11.13. U.K. Biochip Scanner Market Forecast, By End User 11.13.1. Biotechnology & Pharmaceutical Companies 11.13.2. Hospitals & Diagnostics Centers 11.13.3. Academic & Research Institutes 11.14. France Biochip Scanner Market Forecast, By Type 11.14.1. DNA Chips 11.14.2. Lab-On-A-Chip 11.14.3. Protein Chips 11.14.4. Cancer Diagnosis and Treatment 11.14.5. Gene Expression 11.14.6. Single Nucleotide Polymorphism (SNP) Genotyping 11.14.7. Genomics 11.14.8. Drug Discovery 11.14.9. Others (Agricultural Biotechnology, Proteomics, Expression Profiling, High Throughput Screening) 11.15. France Biochip Scanner Market Forecast, By End User 11.15.1. Biotechnology & Pharmaceutical Companies 11.15.2. Hospitals & Diagnostics Centers 11.15.3. Academic & Research Institutes 11.16. Italy Biochip Scanner Market Forecast, By Type 11.16.1. DNA Chips 11.16.2. Lab-On-A-Chip 11.16.3. Protein Chips 11.16.4. Cancer Diagnosis and Treatment 11.16.5. Gene Expression 11.16.6. Single Nucleotide Polymorphism (SNP) Genotyping 11.16.7. Genomics 11.16.8. Drug Discovery 11.16.9. Others (Agricultural Biotechnology, Proteomics, Expression Profiling, High Throughput Screening) 11.17. Italy Biochip Scanner Market Forecast, By End User 11.17.1. Biotechnology & Pharmaceutical Companies 11.17.2. Hospitals & Diagnostics Centers 11.17.3. Academic & Research Institutes 11.18. Spain Biochip Scanner Market Forecast, By Type 11.18.1. DNA Chips 11.18.2. Lab-On-A-Chip 11.18.3. Protein Chips 11.18.4. Cancer Diagnosis and Treatment 11.18.5. Gene Expression 11.18.6. Single Nucleotide Polymorphism (SNP) Genotyping 11.18.7. Genomics 11.18.8. Drug Discovery 11.18.9. Others (Agricultural Biotechnology, Proteomics, Expression Profiling, High Throughput Screening) 11.19. Spain Biochip Scanner Market Forecast, By End User 11.19.1. Biotechnology & Pharmaceutical Companies 11.19.2. Hospitals & Diagnostics Centers 11.19.3. Academic & Research Institutes 11.20. Norway Biochip Scanner Market Forecast, By Type 11.20.1. DNA Chips 11.20.2. Lab-On-A-Chip 11.20.3. Protein Chips 11.20.4. Cancer Diagnosis and Treatment 11.20.5. Gene Expression 11.20.6. Single Nucleotide Polymorphism (SNP) Genotyping 11.20.7. Genomics 11.20.8. Drug Discovery 11.20.9. Others (Agricultural Biotechnology, Proteomics, Expression Profiling, High Throughput Screening) 11.21. Norway Biochip Scanner Market Forecast, By End User 11.21.1. Biotechnology & Pharmaceutical Companies 11.21.2. Hospitals & Diagnostics Centers 11.21.3. Academic & Research Institutes 11.22. Russia Biochip Scanner Market Forecast, By Type 11.22.1. DNA Chips 11.22.2. Lab-On-A-Chip 11.22.3. Protein Chips 11.22.4. Cancer Diagnosis and Treatment 11.22.5. Gene Expression 11.22.6. Single Nucleotide Polymorphism (SNP) Genotyping 11.22.7. Genomics 11.22.8. Drug Discovery 11.22.9. Others (Agricultural Biotechnology, Proteomics, Expression Profiling, High Throughput Screening) 11.23. Russia Biochip Scanner Market Forecast, By End User 11.23.1. Biotechnology & Pharmaceutical Companies 11.23.2. Hospitals & Diagnostics Centers 11.23.3. Academic & Research Institutes 11.24. Rest of Europe Biochip Scanner Market Forecast, By Type 11.24.1. DNA Chips 11.24.2. Lab-On-A-Chip 11.24.3. Protein Chips 11.24.4. Cancer Diagnosis and Treatment 11.24.5. Gene Expression 11.24.6. Single Nucleotide Polymorphism (SNP) Genotyping 11.24.7. Genomics 11.24.8. Drug Discovery 11.24.9. Others (Agricultural Biotechnology, Proteomics, Expression Profiling, High Throughput Screening) 11.25. Rest of Europe Biochip Scanner Market Forecast, By End User 11.25.1. Biotechnology & Pharmaceutical Companies 11.25.2. Hospitals & Diagnostics Centers 11.25.3. Academic & Research Institutes 11.26. Europe Biochip Scanner Market Attractiveness Analysis 11.26.1. By Type 11.26.2. By End User 11.27. PEST Analysis 11.28. Key Trends 11.29. Key Developments 12. Asia Pacific Biochip Scanner Market Analysis 12.1. Key Findings 12.2. Asia Pacific Biochip Scanner Market Overview 12.3. Asia Pacific Biochip Scanner Market Value Share Analysis, By Type 12.4. Asia Pacific Biochip Scanner Market Forecast, By Type 12.4.1. DNA Chips 12.4.2. Lab-On-A-Chip 12.4.3. Protein Chips 12.4.4. Cancer Diagnosis and Treatment 12.4.5. Gene Expression 12.4.6. Single Nucleotide Polymorphism (SNP) Genotyping 12.4.7. Genomics 12.4.8. Drug Discovery 12.4.9. Others (Agricultural Biotechnology, Proteomics, Expression Profiling, High Throughput Screening) 12.5. Asia Pacific Biochip Scanner Market Value Share Analysis, By End User 12.6. Asia Pacific Biochip Scanner Market Forecast, By End User 12.6.1. Biotechnology & Pharmaceutical Companies 12.6.2. Hospitals & Diagnostics Centers 12.6.3. Academic & Research Institutes 12.7. Asia Pacific Biochip Scanner Market Value Share Analysis, by Country 12.8. Asia Pacific Biochip Scanner Market Forecast, by Country 12.8.1. China 12.8.2. India 12.8.3. Japan 12.8.4. South Korea 12.8.5. Australia 12.8.6. Malaysia 12.8.7. Indonesia 12.8.8. ASEAN 12.8.9. Rest of Asia Pacific 12.9. Asia Pacific Biochip Scanner Market Analysis, by Country 12.10. China Biochip Scanner Market Forecast, By Type 12.10.1. DNA Chips 12.10.2. Lab-On-A-Chip 12.10.3. Protein Chips 12.10.4. Cancer Diagnosis and Treatment 12.10.5. Gene Expression 12.10.6. Single Nucleotide Polymorphism (SNP) Genotyping 12.10.7. Genomics 12.10.8. Drug Discovery 12.10.9. Others (Agricultural Biotechnology, Proteomics, Expression Profiling, High Throughput Screening) 12.11. China Biochip Scanner Market Forecast, By End User 12.11.1. Biotechnology & Pharmaceutical Companies 12.11.2. Hospitals & Diagnostics Centers 12.11.3. Academic & Research Institutes 12.12. India Biochip Scanner Market Forecast, By Type 12.12.1. DNA Chips 12.12.2. Lab-On-A-Chip 12.12.3. Protein Chips 12.12.4. Cancer Diagnosis and Treatment 12.12.5. Gene Expression 12.12.6. Single Nucleotide Polymorphism (SNP) Genotyping 12.12.7. Genomics 12.12.8. Drug Discovery 12.12.9. Others (Agricultural Biotechnology, Proteomics, Expression Profiling, High Throughput Screening) 12.13. India Biochip Scanner Market Forecast, By End User 12.13.1. Biotechnology & Pharmaceutical Companies 12.13.2. Hospitals & Diagnostics Centers 12.13.3. Academic & Research Institutes 12.14. Japan Biochip Scanner Market Forecast, By Type 12.14.1. DNA Chips 12.14.2. Lab-On-A-Chip 12.14.3. Protein Chips 12.14.4. Cancer Diagnosis and Treatment 12.14.5. Gene Expression 12.14.6. Single Nucleotide Polymorphism (SNP) Genotyping 12.14.7. Genomics 12.14.8. Drug Discovery 12.14.9. Others (Agricultural Biotechnology, Proteomics, Expression Profiling, High Throughput Screening) 12.15. Japan Biochip Scanner Market Forecast, By End User 12.15.1. Biotechnology & Pharmaceutical Companies 12.15.2. Hospitals & Diagnostics Centers 12.15.3. Academic & Research Institutes 12.16. South Korea Biochip Scanner Market Forecast, By Type 12.16.1. DNA Chips 12.16.2. Lab-On-A-Chip 12.16.3. Protein Chips 12.16.4. Cancer Diagnosis and Treatment 12.16.5. Gene Expression 12.16.6. Single Nucleotide Polymorphism (SNP) Genotyping 12.16.7. Genomics 12.16.8. Drug Discovery 12.16.9. Others (Agricultural Biotechnology, Proteomics, Expression Profiling, High Throughput Screening) 12.17. South Korea Biochip Scanner Market Forecast, By End User 12.17.1. Biotechnology & Pharmaceutical Companies 12.17.2. Hospitals & Diagnostics Centers 12.17.3. Academic & Research Institutes 12.18. Australia Biochip Scanner Market Forecast, By Type 12.18.1. DNA Chips 12.18.2. Lab-On-A-Chip 12.18.3. Protein Chips 12.18.4. Cancer Diagnosis and Treatment 12.18.5. Gene Expression 12.18.6. Single Nucleotide Polymorphism (SNP) Genotyping 12.18.7. Genomics 12.18.8. Drug Discovery 12.18.9. Others (Agricultural Biotechnology, Proteomics, Expression Profiling, High Throughput Screening) 12.19. Australia Biochip Scanner Market Forecast, By End User 12.19.1. Biotechnology & Pharmaceutical Companies 12.19.2. Hospitals & Diagnostics Centers 12.19.3. Academic & Research Institutes 12.20. Malaysia Biochip Scanner Market Forecast, By Type 12.20.1. DNA Chips 12.20.2. Lab-On-A-Chip 12.20.3. Protein Chips 12.20.4. Cancer Diagnosis and Treatment 12.20.5. Gene Expression 12.20.6. Single Nucleotide Polymorphism (SNP) Genotyping 12.20.7. Genomics 12.20.8. Drug Discovery 12.20.9. Others (Agricultural Biotechnology, Proteomics, Expression Profiling, High Throughput Screening) 12.21. Malaysia Biochip Scanner Market Forecast, By End User 12.21.1. Biotechnology & Pharmaceutical Companies 12.21.2. Hospitals & Diagnostics Centers 12.21.3. Academic & Research Institutes 12.22. Indonesia Biochip Scanner Market Forecast, By Type 12.22.1. DNA Chips 12.22.2. Lab-On-A-Chip 12.22.3. Protein Chips 12.22.4. Cancer Diagnosis and Treatment 12.22.5. Gene Expression 12.22.6. Single Nucleotide Polymorphism (SNP) Genotyping 12.22.7. Genomics 12.22.8. Drug Discovery 12.22.9. Others (Agricultural Biotechnology, Proteomics, Expression Profiling, High Throughput Screening) 12.23. Indonesia Biochip Scanner Market Forecast, By End User 12.23.1. Biotechnology & Pharmaceutical Companies 12.23.2. Hospitals & Diagnostics Centers 12.23.3. Academic & Research Institutes 12.24. Rest of Asia Pacific Biochip Scanner Market Forecast, By Type 12.24.1. DNA Chips 12.24.2. Lab-On-A-Chip 12.24.3. Protein Chips 12.24.4. Cancer Diagnosis and Treatment 12.24.5. Gene Expression 12.24.6. Single Nucleotide Polymorphism (SNP) Genotyping 12.24.7. Genomics 12.24.8. Drug Discovery 12.24.9. Others (Agricultural Biotechnology, Proteomics, Expression Profiling, High Throughput Screening) 12.25. Rest of Asia Pacific Biochip Scanner Market Forecast, By End User 12.25.1. Biotechnology & Pharmaceutical Companies 12.25.2. Hospitals & Diagnostics Centers 12.25.3. Academic & Research Institutes 12.26. Asia Pacific Biochip Scanner Market Attractiveness Analysis 12.26.1. By Type 12.26.2. By End User 12.27. PEST Analysis 12.28. Key Trends 12.29. Key Developments 13. Middle East & Africa Biochip Scanner Market Analysis 13.1. Key Findings 13.2. Middle East & Africa Biochip Scanner Market Overview 13.3. Middle East & Africa Biochip Scanner Market Value Share Analysis, By Type 13.4. Middle East & Africa Biochip Scanner Market Forecast, By Type 13.4.1. DNA Chips 13.4.2. Lab-On-A-Chip 13.4.3. Protein Chips 13.4.4. Cancer Diagnosis and Treatment 13.4.5. Gene Expression 13.4.6. Single Nucleotide Polymorphism (SNP) Genotyping 13.4.7. Genomics 13.4.8. Drug Discovery 13.4.9. Others (Agricultural Biotechnology, Proteomics, Expression Profiling, High Throughput Screening) 13.5. Middle East & Africa Biochip Scanner Market Value Share Analysis, By End User 13.6. Middle East & Africa Biochip Scanner Market Forecast, By End User 13.6.1. Biotechnology & Pharmaceutical Companies 13.6.2. Hospitals & Diagnostics Centers 13.6.3. Academic & Research Institutes 13.7. Middle East & Africa Biochip Scanner Market Value Share Analysis, by Country 13.8. Middle East & Africa Biochip Scanner Market Forecast, by Country 13.8.1. GCC 13.8.2. South Africa 13.8.3. Rest of Middle East & Africa 13.9. Middle East & Africa Biochip Scanner Market Analysis, by Country 13.10. GCC Biochip Scanner Market Forecast, By Type 13.10.1. DNA Chips 13.10.2. Lab-On-A-Chip 13.10.3. Protein Chips 13.10.4. Cancer Diagnosis and Treatment 13.10.5. Gene Expression 13.10.6. Single Nucleotide Polymorphism (SNP) Genotyping 13.10.7. Genomics 13.10.8. Drug Discovery 13.10.9. Others (Agricultural Biotechnology, Proteomics, Expression Profiling, High Throughput Screening) 13.11. GCC Biochip Scanner Market Forecast, By End User 13.11.1. Biotechnology & Pharmaceutical Companies 13.11.2. Hospitals & Diagnostics Centers 13.11.3. Academic & Research Institutes 13.12. South Africa Biochip Scanner Market Forecast, By Type 13.12.1. DNA Chips 13.12.2. Lab-On-A-Chip 13.12.3. Protein Chips 13.12.4. Cancer Diagnosis and Treatment 13.12.5. Gene Expression 13.12.6. Single Nucleotide Polymorphism (SNP) Genotyping 13.12.7. Genomics 13.12.8. Drug Discovery 13.12.9. Others (Agricultural Biotechnology, Proteomics, Expression Profiling, High Throughput Screening) 13.13. South Africa Biochip Scanner Market Forecast, By End User 13.13.1. Biotechnology & Pharmaceutical Companies 13.13.2. Hospitals & Diagnostics Centers 13.13.3. Academic & Research Institutes 13.14. Rest of Middle East & Africa Biochip Scanner Market Forecast, By Type 13.14.1. DNA Chips 13.14.2. Lab-On-A-Chip 13.14.3. Protein Chips 13.14.4. Cancer Diagnosis and Treatment 13.14.5. Gene Expression 13.14.6. Single Nucleotide Polymorphism (SNP) Genotyping 13.14.7. Genomics 13.14.8. Drug Discovery 13.14.9. Others (Agricultural Biotechnology, Proteomics, Expression Profiling, High Throughput Screening) 13.15. Rest of Middle East & Africa Biochip Scanner Market Forecast, By End User 13.15.1. Biotechnology & Pharmaceutical Companies 13.15.2. Hospitals & Diagnostics Centers 13.15.3. Academic & Research Institutes 13.16. Middle East & Africa Biochip Scanner Market Attractiveness Analysis 13.16.1. By Type 13.16.2. By End User 13.17. PEST Analysis 13.18. Key Trends 13.19. Key Developments 14. South America Biochip Scanner Market Analysis 14.1. Key Findings 14.2. South America Biochip Scanner Market Overview 14.3. South America Biochip Scanner Market Value Share Analysis, By Type 14.4. South America Biochip Scanner Market Forecast, By Type 14.4.1. DNA Chips 14.4.2. Lab-On-A-Chip 14.4.3. Protein Chips 14.4.4. Cancer Diagnosis and Treatment 14.4.5. Gene Expression 14.4.6. Single Nucleotide Polymorphism (SNP) Genotyping 14.4.7. Genomics 14.4.8. Drug Discovery 14.4.9. Others (Agricultural Biotechnology, Proteomics, Expression Profiling, High Throughput Screening) 14.5. South America Biochip Scanner Market Value Share Analysis, By End User 14.6. South America Biochip Scanner Market Forecast, By End User 14.6.1. Biotechnology & Pharmaceutical Companies 14.6.2. Hospitals & Diagnostics Centers 14.6.3. Academic & Research Institutes 14.7. South America Biochip Scanner Market Value Share Analysis, by Country 14.8. South America Biochip Scanner Market Forecast, by Country 14.8.1. Brazil 14.8.2. Mexico 14.8.3. Argentina 14.8.4. Rest of South America 14.9. South America Biochip Scanner Market Analysis, by Country 14.10. Brazil Biochip Scanner Market Forecast, By Type 14.10.1. DNA Chips 14.10.2. Lab-On-A-Chip 14.10.3. Protein Chips 14.10.4. Cancer Diagnosis and Treatment 14.10.5. Gene Expression 14.10.6. Single Nucleotide Polymorphism (SNP) Genotyping 14.10.7. Genomics 14.10.8. Drug Discovery 14.10.9. Others (Agricultural Biotechnology, Proteomics, Expression Profiling, High Throughput Screening) 14.11. Brazil Biochip Scanner Market Forecast, By End User 14.11.1. Biotechnology & Pharmaceutical Companies 14.11.2. Hospitals & Diagnostics Centers 14.11.3. Academic & Research Institutes 14.12. Mexico Biochip Scanner Market Forecast, By Type 14.12.1. DNA Chips 14.12.2. Lab-On-A-Chip 14.12.3. Protein Chips 14.12.4. Cancer Diagnosis and Treatment 14.12.5. Gene Expression 14.12.6. Single Nucleotide Polymorphism (SNP) Genotyping 14.12.7. Genomics 14.12.8. Drug Discovery 14.12.9. Others (Agricultural Biotechnology, Proteomics, Expression Profiling, High Throughput Screening) 14.13. Mexico Biochip Scanner Market Forecast, By End User 14.13.1. Biotechnology & Pharmaceutical Companies 14.13.2. Hospitals & Diagnostics Centers 14.13.3. Academic & Research Institutes 14.14. Argentina Biochip Scanner Market Forecast, By Type 14.14.1. DNA Chips 14.14.2. Lab-On-A-Chip 14.14.3. Protein Chips 14.14.4. Cancer Diagnosis and Treatment 14.14.5. Gene Expression 14.14.6. Single Nucleotide Polymorphism (SNP) Genotyping 14.14.7. Genomics 14.14.8. Drug Discovery 14.14.9. Others (Agricultural Biotechnology, Proteomics, Expression Profiling, High Throughput Screening) 14.15. Argentina Biochip Scanner Market Forecast, By End User 14.15.1. Biotechnology & Pharmaceutical Companies 14.15.2. Hospitals & Diagnostics Centers 14.15.3. Academic & Research Institutes 14.16. Rest of South America Biochip Scanner Market Forecast, By Type 14.16.1. DNA Chips 14.16.2. Lab-On-A-Chip 14.16.3. Protein Chips 14.16.4. Cancer Diagnosis and Treatment 14.16.5. Gene Expression 14.16.6. Single Nucleotide Polymorphism (SNP) Genotyping 14.16.7. Genomics 14.16.8. Drug Discovery 14.16.9. Others (Agricultural Biotechnology, Proteomics, Expression Profiling, High Throughput Screening) 14.17. Rest of South America Biochip Scanner Market Forecast, By End User 14.17.1. Biotechnology & Pharmaceutical Companies 14.17.2. Hospitals & Diagnostics Centers 14.17.3. Academic & Research Institutes 14.18. South America Biochip Scanner Market Attractiveness Analysis 14.18.1. By Type 14.18.2. By End User 14.19. PEST Analysis 14.20. Key Trends 14.21. Key Developments 15. Company Profiles 15.1. Market Share Analysis, by Company 15.2. Competition Matrix 15.2.1. Competitive Benchmarking of key players by price, presence, market share, Vehicles and R&D investment 15.2.2. New Product Launches and Product Enhancements 15.2.3. Market Consolidation 15.2.3.1. M&A by Regions, Investment and Vehicles 15.2.3.2. M&A Key Players, Forward Integration and Backward Integration 15.3. Company Profiles: Key Players 15.3.1. Agilent Technologies, Inc 15.3.1.1. Company Overview 15.3.1.2. Financial Overview 15.3.1.3. Product Portfolio 15.3.1.4. Business Strategy 15.3.1.5. Recent Developments 15.3.1.6. Development Footprint 15.3.2. Bio-Rad Laboratories, Inc 15.3.3. Cepheid Inc 15.3.4. Fluidigm Corporation 15.3.5. GE Healthcare 15.3.6. Hoffman-La-Roche Ltd 15.3.7. Illumina, Inc 15.3.8. Ocimum Biosolutions Ltd 15.3.9. PerkinElmer, Inc 15.3.10. Takara Bio Inc 15.3.11. Thermo Fisher Scientific Inc 15.3.12. seibersdorf research 15.3.13. Merck Millipore 15.3.14. Sigma-Aldrich Corporation 15.3.15. Abbott Laboratories 16. Primary Key Insights

About This Report

Report ID 70484
Category Electronics
Published Date August 2020
Updated Date
Contact Us